Bone marrow is known as the site of hematopoiesis. What is not being described in
textbooks of immunology is the fact that bone marrow is not only a generative, but also an …

Despite considerable clinical success, the potential of cancer immunotherapy is restricted by
a lack of tumour-targeting strategies. Treatment requires systemic delivery of cytokines or …

Introduction Cervical cancer accounts for one of most common cancers among women of
reproductive age. Oncolytic virotherapy has emerged as a promising immunotherapy …

Simple Summary The standard of care for patients with primary glioblastoma multiforme
consists of neurosurgery, radiochemotherapy, and maintenance chemotherapy. We added …

Oncolytic viruses and combinatorial immunotherapy for cancer (this Special Issue) are both
part of cancer treatment at IOZK. This review focusses on an individual multimodal cancer …

Glioblastoma (GBM) remains an orphan cancer disease with poor outcome. Novel treatment
strategies are needed. Immunotherapy has several modes of action. The addition of active …

Bone marrow and the central nervous system are both protected by bone. The two systems
are interconnected not only structurally but also functionally. In both systems specialized …

Recently, immunotherapy has become a hopeful option for cancer therapy. Taking
advantage of pathogens is a well-established method of cancer immunotherapy. It has been …

Glioblastoma (GBM) remains an orphan cancer disease with poor outcome. Novel treatment
strategies are needed. Immunotherapy has several modes of action. The addition of active …

Methods: Using half dose of NDV (TCID50 (50% tissue culture infective dose) single dose
3× 105), virus loaded nanoparticles were prepared by green synthesis approach through …